• English
  • Español
  • Neurosoft Bioelectronics – SOFT ECoG

    Home > Success Stories >
    EIC Accelerator / Direct funding by SERI
    With more than 50 million cases worldwide, epilepsy is one of the most common brain disorders. Even though some treatments exist to alleviate this reality, anti-epileptic drugs fail in 30% of the patients, and cases sent to neurosurgeons often involve risks of complications and re-operation.

    SOFT ECoG, developed by Neurosoft Bioelectronics, is a high-resolution and soft brain implant for monitoring and surgical treatment of epilepsy. This device will improve the rate of surgery, reducing associated problems and revolutionizing current treatments thanks to its soft materials, accurate recording of electric signals and more precise brain stimulation.

    Neurosoft’s product has already been tested in various animal models, showing its efficacy and safety. Now, they are ready to move a step forward and develop the next-generation of neural implants.

    Evolution was of great help in preparing our submission to this program. Indeed, the number of documents and the reporting mechanisms are very long and complex, and we definitely can see the added benefit and time savings. 

    Moreover, we took advantage of the expertise of Evolution to make sure we focus on and highlight the important and relevant aspects of our business for such grants. Finally, we were quite impressed by how quickly the team members of Evolution understood what we are doing and grasped the essential concepts, even though these can be very technical.

    Nicolas Vachicouras

    CEO, Neurosoft Bioelectronics